The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, producing billions in income, its patent expiration created a deluge of knock-off medications, significantly eroding its position . While some pharmaceutical companies may seek to capitalize on similar conditions , the pres